A medication that has long been used to treat high blood pressure could also help make an important class of cancer drugs ...

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

The metastatic castration-resistant prostate cancer market is poised for substantial growth over the coming years, driven by ...

Organizations have spent decades becoming more modular, breaking themselves into agile teams, business units, and platforms ...

Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer ...

bDepartment of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore cHealthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine ...

BioLineRx & Hemispherian announce new preclinical data demonstrating strong synergistic effect between GLIX1 and PARP inhibitor in a patient-derived ovarian cancer xenograft model ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology ...

Scientists have finally uncovered how bacteria naturally create multiple versions of powerful anti-cancer drugs, solving a mystery that has frustrated researchers for decades.

By analyzing fabrication methods and interface design, the authors identify key factors that control efficiency, speed, and stability, and outline practical guidelines for developing more reliable ...

Berlin team's efficiency record for 1.081cm 2 cell certified in the Solar Cell Efficiency 'Green" Tables A Berlin-based team ...

India and Japan on Thursday unveiled an expansive agenda to elevate their Special Strategic and Global Partnership, with Prime Minister Narendra Modi and Japanese Prime Minister Sanae Takaichi ...